Painpatrol Cbd Professional Pain Relief

Description

The product is a Clinical Strength Menthol Formula designed for professional pain relief, specifically targeting arthritis, joints, and muscles. It contains 150 mg of CBD, along with additional active ingredients including Glucosamine, Chondroitin, Arnica, and Boswellia. The formulation is delivered in a 3 FL OZ (88 mL) container and features a No Mess Applicator for ease of use.

Uses and Indications

This drug is indicated for the temporary relief of foot, ankle, and leg pain associated with various conditions, including arthritis, muscle aches, muscle strains, muscle sprains, and joint pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to administer the medication strictly as directed. It is contraindicated for use in children under 12 years of age.

For application, the product should be rolled onto the affected area, with a maximum frequency of four times daily. Prior to each use, it is essential to shake the container well to ensure proper mixing of the formulation.

Contraindications

The product is contraindicated for use on wounds or irritated skin due to the potential for exacerbating the condition. Additionally, it should not be used with tight bandaging or in conjunction with a heating pad, as this may lead to adverse effects.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from excessive heat or open flame. Healthcare professionals should advise patients to consult a doctor prior to use if they have sensitive skin or are currently taking any blood thinners.

It is contraindicated to apply this product on wounds or irritated skin. Additionally, patients should be instructed not to bandage the area tightly or use it in conjunction with a heating pad, as this may exacerbate adverse effects. Following application, it is essential for patients to wash their hands with cool water to prevent unintended contact with other areas of the body or surfaces.

Pregnant or breastfeeding individuals should seek guidance from a healthcare professional before using this product. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate contact with a doctor or poison control center is necessary.

Patients should be advised to discontinue use and consult a doctor if their condition worsens, if pain persists for more than 7 days, or if symptoms improve only to reoccur within a few days. Regular monitoring of the patient's condition is recommended to ensure safety and efficacy.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from excessive heat or open flame.

Before using the product, patients are advised to consult a doctor if they have sensitive skin or are taking any blood thinners. The product should not be applied to wounds or irritated skin, and it is important to avoid tight bandaging or the use of heating pads in conjunction with the product.

Patients are also instructed to wash their hands with cool water after application. For those who are pregnant or breastfeeding, it is recommended to seek advice from a health professional prior to use.

The product should be kept out of reach of children. In the event of accidental ingestion, patients should contact a doctor or poison control center immediately.

Patients are advised to discontinue use and consult a doctor if their condition worsens, if pain persists for more than 7 days, or if the condition clears up and then reoccurs within a few days.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking any anticoagulants or blood thinners. The combination may increase the risk of bleeding or other adverse effects. Monitoring of coagulation parameters may be warranted to ensure patient safety and to adjust dosages as necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Painpatrol Cbd Professional Pain Relief (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. It is important to keep the product out of reach of children. In the event of accidental ingestion, healthcare professionals should be contacted immediately, or the local poison control center should be notified.

Geriatric Use

Elderly patients should be considered with caution when prescribing this medication. The safety and efficacy of the drug have not been established in pediatric patients, specifically those under 12 years of age. Therefore, it is imperative to avoid its use in this population.

Healthcare providers are advised to closely monitor geriatric patients for any adverse effects and to consider potential age-related pharmacokinetic and pharmacodynamic changes that may necessitate dosage adjustments. Careful assessment of the patient's overall health status and concurrent medications is recommended to mitigate risks associated with polypharmacy and age-related sensitivities.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to keep the medication out of reach of children to prevent accidental ingestion. Should an accidental swallowing occur, immediate action is required. Healthcare professionals should advise caregivers to contact a physician or a poison control center without delay for further guidance.

Prompt medical evaluation is essential to assess the situation and determine the appropriate management steps. The healthcare provider may recommend monitoring for potential symptoms associated with the overdosage, although specific symptoms are not detailed in the provided information.

In summary, the key actions in the case of overdosage include ensuring the medication is inaccessible to children and seeking immediate medical assistance if ingestion occurs.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should be instructed to contact a doctor or poison control center immediately.

Patients should be informed to discontinue use and consult a doctor if their condition worsens, if pain persists for more than 7 days, or if symptoms improve and then reoccur within a few days. It is important to emphasize that the medication should not be applied to wounds or irritated skin.

Additionally, patients should be cautioned against bandaging the area tightly or using the medication in conjunction with a heating pad. After application, patients are advised to wash their hands thoroughly with cool water to prevent unintended exposure.

Healthcare providers should also recommend that patients consult a doctor prior to use if they have sensitive skin or are currently taking any blood thinners, ensuring that all safety considerations are addressed.

Storage and Handling

The product is supplied in a configuration that ensures optimal preservation of its integrity. It is essential to store the product in a cool, dry place, maintaining the cap tightly closed to prevent contamination and degradation. Proper storage conditions are crucial for maintaining the product's efficacy and safety.

Additional Clinical Information

The product is administered topically, with a recommended application of no more than four times daily. Clinicians should advise patients to shake the product well before each use.

Patients should be counseled that the product is for external use only and is flammable; it should be kept away from excessive heat or open flames. They should consult a doctor prior to use if they have sensitive skin or are taking blood thinners. Pregnant or breastfeeding patients are also advised to seek professional guidance before use. It is important to keep the product out of reach of children, and in the event of accidental ingestion, patients should contact a doctor or poison control center immediately. Patients should discontinue use and consult a doctor if their condition worsens, if pain persists for more than seven days, or if symptoms resolve and then recur within a few days.

Drug Information (PDF)

This file contains official product information for Painpatrol Cbd Professional Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)